Details for New Drug Application (NDA): 209325
✉ Email this page to a colleague
The generic ingredient in MIGLUSTAT is miglustat. There are two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the miglustat profile page.
Summary for 209325
Tradename: | MIGLUSTAT |
Applicant: | Breckenridge |
Ingredient: | miglustat |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 100MG | ||||
Approval Date: | Feb 3, 2022 | TE: | AB | RLD: | No |
Complete Access Available with Subscription